Thyroid cancer MR molecular imaging via SHP2-targeted nanoparticles

References

• Yoo J, Ahn HS, Kim SJ, Park SH, Seo M, Chong S. Evaluation of diagnostic performance of screening thyroid ultrasonography and imaging findings of screening-detected thyroid cancer. Cancer Res Treat. 2018;50(1):11–18. doi:10.4143/crt.2016.60028231691
   PubMedGoogle Scholar
• Lan XB, Zhang H. An introduction of surgical update in 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Zhonghua Wai Ke Za Zhi. 2016;54(3):172–176. doi:10.3760/cma.j.issn.0529-5815.2016.03.00426932883
   PubMedGoogle Scholar
• Stefano V, Giuliano S, Francesco R, et al. Cancer rate of the indeterminate lesions at low or high risk according to italian system for reporting of thyroid FNA. Front Endocrinol (Lausanne). 2018;9:371. doi:10.3389/fendo.2018.0042030050499
   PubMedGoogle Scholar
• Nikiforova MN, Mercurio S, Wald AI, et al. Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules. Cancer. 2018;124:1682–1690. doi:10.1002/cncr.v124.829345728
   PubMedGoogle Scholar
• Di HT, Wahl RL. Molecular imaging in thyroid cancer. Cancer Imaging Off Publ Int Cancer Imaging Soc. 2010;10(1):1.
   Web of Science ®Google Scholar
• Ahn BC. Personalized medicine based on theranostic radioiodine molecular imaging for differentiated thyroid cancer. Biomed Res Int. 2016;2016(5):1–9.
   Google Scholar
• Wong KK, Dvorak RA, Marzola MC, Grassetto G, Gross MD, Rubello D. Molecular imaging in the management of thyroid cancer. Q J Nucl Med Mol Imaging. 2011;55(5):541–559.22019711
   PubMed Web of Science ®Google Scholar
• Santhanam P, Solnes LB, Rowe SB. Molecular imaging of advanced thyroid cancer: iodinated radiotracers and beyond. Medical Oncology. 2017;34(12):189. doi:10.1007/s12032-017-1051-x29086115
   PubMedGoogle Scholar
• Zhongqian H, Yang B, Tiankuan L, Jia L. Thyroid cancer detection by ultrasound molecularimaging with SHP2-targeted perfluorocarbon nanoparticles. Contrast Media Mol Imaging. 2018;7.
   Google Scholar
• Sun Y, Zheng Y, Ran H, et al. Corrigendum to “Superparamagnetic PLGA-iron oxide microcapsules for dual-modality US/MR imaging and high intensity focused US breast cancer ablation” [Biomaterials 33 (2012) 5854-5864]. Biomaterials. 2015;64:1. doi:10.1016/j.biomaterials.2015.06.02126100937
   PubMedGoogle Scholar
• Devulapally R, Foygel K, Sekar TV, Willmann JK, Paulmurugan R. Gemcitabine and antisense-microRNA co-encapsulated PLGA-PEG polymer nanoparticles for hepatocellular carcinoma therapy. ACS Appl Mater Interfaces. 2016;8(49):33412. doi:10.1021/acsami.6b0815327960411
   PubMed Web of Science ®Google Scholar
• Devulapally R, Lee T, Barghava-Shah A, et al. Ultrasound-guided delivery of thymidine kinase-nitroreductase dual therapeutic genes by PEGylated-PLGA/PIE nanoparticles for enhanced triple negative breast cancer therapy. Nanomedicine. 2018;13(9):1051–1066. doi:10.2217/nnm-2017-032829790803
   PubMedGoogle Scholar
• Devulapally R, Sekar NM, Sekar TV, et al. Polymer nanoparticles mediated co-delivery of antimir-10b and antimiR-21 for achieving triple negative breast cancer therapy. ACS Nano. 2015;9(3):2290–2302. doi:10.1021/nn507465d25652012
   PubMedGoogle Scholar
• Noormehr H, Zavaran HA, Soudi S, Beyzay F. Enhancement of Th1 immune response against Leishmania cysteine peptidase A, B by PLGA nanoparticle. Int Immunopharmacol. 2018;59:97–105. doi:10.1016/j.intimp.2018.03.01229649772
   PubMed Web of Science ®Google Scholar
• Wang T, Hurwitz O, Shimada SG, et al. Anti-nociceptive effects of bupivacaine-encapsulated PLGA nanoparticles applied to the compressed dorsal root ganglion in mice. Neurosci Lett. 2018;668:154–158. doi:10.1016/j.neulet.2018.01.03129355697
   PubMedGoogle Scholar
• Burks SR, Barth ED, Martin SS, et al. Targeted delivery of molecular probes for in vivo, electron paramagnetic resonance imaging. 26th Southern Biomedical Engineering Conference SBEC 2010, April 30 - May 2, 2010, College Park, Maryland, USA; 2010.
   Google Scholar
• Mulder WJM, Koole R, Brandwijk RJ, et al. Quantum dots with a paramagnetic coating as a bimodal molecular imaging probe. Nano Lett. 2006;6(1):1–6. doi:10.1021/nl051935m16402777
   PubMedGoogle Scholar
• Li Q, Li C, Tong W. Nile red loaded PLGA nanoparticles surface modified with Gd-DTPA for potential dual-modal imaging. J Nanosci Nanotechnol. 2016;16(6):5569–5576. doi:10.1166/jnn.2016.1173527427598
   PubMed Web of Science ®Google Scholar
• Amanlou M, Siadat SD, Ebrahimi SE, et al. Gd3+-DTPA-DG: novel nanosized dual anticancer and molecular imaging agent. Int J Nanomedicine. 2011;6(1):747–763. doi:10.2147/IJN.S1764821589643
   PubMedGoogle Scholar
• Wu B, S T L, Deng K, et al. MRI-guided targeting delivery of doxorubicin with reduction-responsive lipid-polymer hybrid nanoparticles. Int J Nanomedicine. 2017;12:6871–6882. doi:10.2147/IJN.S14304829066883
   PubMedGoogle Scholar
• Jing Z, Hao G, Yao C, et al. Paramagnetic albumin decorated CuInS2/ZnS QDs for CD133+ glioma bimodal MR/fluorescence targeted imaging. J Mater Chem B. 2016;4(23):4110–4118. doi:10.1039/C6TB00834H
   PubMed Web of Science ®Google Scholar
• Park KE, Noh YW, Kim A, Lim YT. Hyaluronic acid-coated nanoparticles for targeted photodynamic therapy of cancer guided by near-infrared and MR imaging. Carbohydr Polym. 2017;157:476–483. doi:10.1016/j.carbpol.2016.10.01527987951
   PubMed Web of Science ®Google Scholar
• Alberti D, Protti N, Franck M, et al. Theranostic nanoparticles loaded with imaging probes and rubrocurcumin for combined cancer therapy by folate receptor targeting. Chemmedchem. 2017;12(7):502. doi:10.1002/cmdc.20170036828217982
   PubMedGoogle Scholar
• Jianxin L, Fenfen X, ZhongQian H, et al. Low intensity focused ultrasound-activatable nanodroplets as a theranostic agent for noninvasive cancer molecular imaging imaging and drug delivery. Biomater Sci. 2018;6:2838–2849. doi:10.1039/c8bm00726h30229771
   PubMedGoogle Scholar
• Turino LN, Ruggiero M, Stefania R, et al. Ferritin decorated PLGA/Paclitaxel loaded nanoparticles endowed with an enhanced toxicity towards MCF-7 breast tumour cells. Bioconjug Chem. 2017;28(4):1283–1290. doi:10.1021/acs.bioconjchem.7b0009628301933
   PubMedGoogle Scholar
• Ratzinger G, Agrawal P, Körner W, et al. Surface modification of PLGA nanospheres with Gd-DTPA and Gd-DOTA for high-relaxivity MRI contrast agents. Biomaterials. 2010;31(33):8716–8723. doi:10.1016/j.biomaterials.2010.07.09520797782
   PubMed Web of Science ®Google Scholar
• Chen Z, Yu D, Liu C, et al. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent. J Drug Target. 2011;19(8):657–665. doi:10.3109/1061186X.2010.53172721091273
   PubMed Web of Science ®Google Scholar
• Gill MR, Menon JU, Jarman PJ, et al. 111In-labelled polymeric nanoparticles incorporating a ruthenium-based radiosensitizer for EGFR-targeted combination therapy in oesophageal cancer cells. Nanoscale. 2018;10:10596–10608. doi:10.1039/C7NR09606B29808844
   PubMed Web of Science ®Google Scholar